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Background
Drug hypersensitivity reactions (DHRs) are rare but
potentially fatal types of adverse drug reactions (ADRs)
that develop in susceptible patients following exposure
to certain drugs including sulfonamides. The diagnosis
of this type of ADRs is challenging and currently
depends on clinical expertise. A safe and reliable in vitro
test to diagnose DHRs would be a major advance in
patient care and in evaluation of possible serious ADRs
during drug development and clinical trials. Current
available in vitro tests including the lymphocyte toxicity
assay (LTA) and the lymphocyte transformation test
(LTT) are cumbersome and expensive, and their predictive
values are undefined. We have recently developed a novel
in vitro diagnostic test for DHRs, the in vitro platelet toxi-
city assay (iPTA) to test patient susceptibility to DHS. The
aim of this study was to evaluate the predictive value of
the iPTA in diagnosis of DHRs to sulfonamide antibiotics.
Method
We have recruited 66 individuals (36 DHS-sulfa patients
and 30 healthy controls) to participate in the study. The
DHR cases were referred and diagnosed based on rigorous
internationally accepted criteria. Blood samples were
obtained and both LTA and iPTA were performed
independently. Results were then analyzed to determine
the degree of agreement between the likelihood of the
occurrence of the reaction as determined clinically and the
performance of the two diagnostic approaches.
Results
There was concentration-dependent toxicity in the cells of
patients when incubated with the reactive hydroxylamine
metabolite of sulfamethoxazole for both the LTA and
iPTA (p<0.05) and toxicity was significantly greater for the
cells of patients versus controls (p<0.05). The tests had a
high degree of agreement (correlation coefficient: R2 =
0.97). The iPTA was significantly more sensitive than the
conventional LTA test in detecting the susceptibility of
patient cells to in vitro toxicity (p<0.05).
Conclusion
The novel iPTA has considerable potential as an investiga-
tive tool for DHS as it is cheaper to perform and requires
no special reagents that make it an excellent candidate for
wider use. The iPTA has also a greater sensitivity in
detecting patients with predisposition to develop DHRs to
sulfonamides and other drugs and thus can be used to
screen for susceptible patients prior to drug prescribing
and during drug development process.
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